<img src="https://secure.office-information-24.com/785669.png" style="display:none;">
Glossary

ICH Q10

Full name: ICH Q10, Pharmaceutical Quality System
ICH Q10 is an internationally harmonized guideline describing a model for an effective pharmaceutical quality system, developed by the International Council for Harmonisation to promote consistent, high-quality medicine development and manufacturing across global markets. Adopted in 2008, ICH Q10 builds on Good Manufacturing Practice with a more holistic, lifecycle-based approach emphasizing continuous improvement, and is one part of a three-guideline model alongside ICH Q8, covering pharmaceutical development, and ICH Q9, covering quality risk management. 

Quick facts

Category Internationally harmonized pharmaceutical quality system model
Used by Pharmaceutical manufacturing and drug development
Also called PQS (Pharmaceutical Quality System)
Related standards GMP, FDA 21 CFR Part 210/211
Related processes CAPA, change control, management review, supplier evaluation
Semantic match ICH Q10, Pharmaceutical Quality System, PQS, ICH Q8 Q9 Q10 model

What is ICH Q10?

ICH Q10 describes a model for an effective pharmaceutical quality system, referred to as the PQS, intended to help pharmaceutical manufacturers achieve consistent product quality and continuous improvement across the entire product lifecycle, from development through commercial manufacturing and eventual discontinuation.

The guideline identifies four major requirements for a robust PQS: a comprehensive quality system covering the full lifecycle, clearly defined management responsibilities, continual monitoring and improvement of process and product quality, and ongoing enhancement of the PQS itself over time.

ICH Q10 is part of a three-part harmonized model alongside ICH Q8, covering pharmaceutical development, and ICH Q9, covering quality risk management. Together, these guidelines encourage a more holistic, science- and risk-based approach to pharmaceutical quality than earlier, more prescriptive GMP frameworks alone.

Why is ICH Q10 important?

ICH Q10 promotes international regulatory harmonization, helping pharmaceutical companies operating across multiple markets, including the US, EU and Japan, work toward a more consistent quality system model rather than navigating entirely separate regional expectations.

The guideline's emphasis on lifecycle thinking and continuous improvement encourages manufacturers to view quality as an ongoing discipline rather than a one-time certification event, aligning with modern regulatory expectations for proactive quality management.

Because ICH Q10 explicitly addresses management responsibility, it reinforces that pharmaceutical quality is a leadership accountability, not solely a technical or compliance department function.

How does ICH Q10 work?

ICH Q10's four major PQS elements include:

  1. Process performance and product quality monitoring. Continuously monitor performance to detect and address variation.
  2. CAPA system. Investigate deviations, determine root cause, and implement corrective and preventive actions.
  3. Change management. Evaluate and control proposed changes throughout the product lifecycle.
  4. Management review. Conduct periodic leadership review of PQS performance and effectiveness.
  5. Knowledge management. Capture and apply product and process knowledge across the lifecycle.
  6. Quality risk management. Apply risk-based thinking, often aligned with ICH Q9, throughout quality decisions.

ICH Q8 vs. Q9 vs. Q10

Comparison ICH Q8 ICH Q9 ICH Q10
Focus Pharmaceutical development Quality risk management Pharmaceutical quality system

Real-world examples of ICH Q10

A pharmaceutical manufacturer builds its PQS around ICH Q10's four core elements, aligning CAPA, change management and management review into one coordinated quality framework.

A contract manufacturer markets itself as "Q10 and Q8 compliant" to attract large pharmaceutical partners seeking suppliers with a mature, lifecycle-based quality system.

A drug company implements ICH Q10's knowledge management principles, systematically capturing lessons learned from process deviations to inform future product development decisions.

Regulations and standards related to ICH Q10

ICH Q10 was adopted through the International Council for Harmonisation process and has been endorsed by regulatory authorities including the European Medicines Agency, though it functions as a harmonized guideline rather than a directly enforceable regulation on its own.

ICH Q10 does not replace existing predicate rules such as FDA 21 CFR Parts 210/211, but rather organizes and elevates how those underlying cGMP requirements are approached, encouraging a more integrated, lifecycle-based quality system.

How QT9 helps with ICH Q10

QT9 QMS ICH Q10 capabilities

  • Align with the four core elements of ICH Q10: process monitoring, CAPA, change management and management review.
  • Centralize quality documentation, supported by QT9 ERP operational data access.
  • Drive continual improvement with connected quality and operations data.
  • Standardize and control changes across documents, products and equipment.
  • Use real-time dashboards and reports to monitor quality KPIs and process trends.
  • Support risk-based control and global regulatory compliance expectations.

Request a QMS Demo Explore ICH Q10 Compliance →

See QT9 Software in Action

Discover how QT9 Software helps manufacturers improve efficiency, strengthen compliance and connect quality management and ERP processes within one integrated platform.

Common mistakes with ICH Q10

Common mistakes include treating ICH Q10 as a checklist of documentation requirements rather than genuinely embedding lifecycle thinking and continuous improvement into daily quality decisions.

Other problems include underinvesting in knowledge management, missing the opportunity to systematically capture and apply lessons learned across the product lifecycle as the guideline intends.

Frequently asked questions

The four major elements are process performance and product quality monitoring, a CAPA system, change management, and management review, together supporting a comprehensive, lifecycle-driven pharmaceutical quality system.
ICH Q8 covers pharmaceutical development, ICH Q9 covers quality risk management, and ICH Q10 covers the pharmaceutical quality system itself, together forming a harmonized three-part model for modern pharmaceutical quality.
Not directly. ICH Q10 functions as a harmonized guideline endorsed by regulatory authorities such as the European Medicines Agency, organizing expectations around existing GMP predicate rules rather than serving as a standalone, independently enforceable regulation.
ICH Q10 was adopted in 2008, developed under the International Council for Harmonisation to promote a more consistent, holistic approach to pharmaceutical quality across global regulatory regions.
No. ICH Q10 does not replace existing GMP predicate rules such as FDA 21 CFR Parts 210/211, but rather organizes and elevates how those underlying requirements are approached within a more integrated quality system.
ICH Q10 was developed by the International Council for Harmonisation, an organization established in 1990 with regulatory and industry participation from regions including Europe, the United States and Japan.

Related quality management terms

Related content

Ready to Transform Your Business?

See how QT9 Software helps manufacturers simplify operations, improve traceability and drive continuous improvement with integrated quality management and ERP software.

Last reviewed: July 21, 2026